Iridex (IRIX) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Iridex (IRIX) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 100.22% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -35.05% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.28% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | 56.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 56.26% |
| Jan 3, 2026 | 84.54% |
| Sep 27, 2025 | -125.81% |
| Jun 28, 2025 | -93.42% |
| Mar 29, 2025 | 86.01% |
| Dec 28, 2024 | 46.25% |
| Sep 28, 2024 | -21.72% |
| Jun 29, 2024 | -60.02% |
| Mar 30, 2024 | 50.55% |
| Sep 30, 2023 | -43.02% |
| Jul 1, 2023 | 73.56% |
| Apr 1, 2023 | 48.35% |
| Dec 31, 2022 | 26.23% |
| Oct 1, 2022 | 52.08% |
| Jul 2, 2022 | -16.25% |
| Apr 2, 2022 | -32.10% |
| Jan 1, 2022 | 20.63% |
| Oct 2, 2021 | 53.67% |
| Jul 3, 2021 | 60.53% |
| Apr 3, 2021 | 41.72% |